Lenacapavir, a new anti-HIV injection, will be available in Kenya starting January 2026, costing Sh6,000 per dose and providing six months of protection.

• The shot represents a significant advancement in HIV prevention, offering a long-lasting alternative to daily oral PrEP pills.
• Andrew Mulwa, the Head of the National AIDS and STD Control Programme (NASCOP), highlighted its implications for those facing adherence challenges.
• The World Health Organization (WHO) has endorsed Lenacapavir, recommending it as a convenient option alongside existing prevention methods.